Integra LifeSciences Holdings Corporation
corporate_fare Company Profile
Integra LifeSciences Holdings Corporation (NASDAQ:IART) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for IART at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Integra LifeSciences Files Shelf Registration for Future Capital Raises
- Integra LifeSciences Reports Massive $511M Goodwill Impairment, Deep Net Loss Amid Regulatory & Tariff Headwinds
- Integra LifeSciences Reports Significant FY2025 GAAP Loss Driven by $511M Impairment; Q4 Adjusted EPS Declines, Provides Modest 2026 Guidance
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.64B
Net Income
-$516.47M
Diluted EPS
-$6.74
Op. Cash Flow
$50.38M
Free Cash Flow
-$31.05M
Gross Profit
$831.62M
Operating Income
-$493.37M
Cash & Equivalents
$235.05M
Debt / Equity
0.00×
Net Margin
-31.6%
Shares Outstanding
76.67M sh
Source: 10-K · filed 2026-02-26 · accession 0000917520-26-000011
show_chartPrice Chart
Loading chart...
feed IART - Filings & News (Page 2)
IART
Feb 26, 2026, 4:59 PM EST
Price at Filing:
$11.33
Real-time Price:
$12.99
Change:
+$1.66 (+15%)
Market Cap:
$1.031B
IART
Feb 26, 2026, 4:02 PM EST
Price at Filing:
$11.33
Real-time Price:
$12.99
Change:
+$1.66 (+15%)
Market Cap:
$1.031B
IART
Feb 26, 2026, 6:15 AM EST
Price at Filing:
$11.59
Real-time Price:
$12.99
Change:
+$1.40 (+12%)
Market Cap:
$1.031B